Searchable abstracts of presentations at key conferences in endocrinology

ea0065oc1.1 | Metabolism and Obesity | SFEBES2019

Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue

Schiffer Lina , Sinclair Alexandra J , O'Reilly Michael W , Westgate Connar , Mashood Afeefa , Palmer Elliot , Gilligan Lorna C , Singhal Rishi , Taylor Angela E , Dunn Warwick B , Arlt Wiebke , Storbeck Karl-Heinz

Polycystic ovary syndrome (PCOS) affects 10% of women and is associated with an increased risk of type 2 diabetes and fatty liver disease. Androgen excess is an important driver of metabolic risk in PCOS. In adipose tissue from women with PCOS, increased activation of androstenedione (A4) to testosterone (T) by the enzyme AKR1C3 results in systemic lipotoxicity. Recent in-vitro studies also demonstrated that T and 11-ketotestosterone (11KT) activate the androgen recep...

ea0065oc1.5 | Metabolism and Obesity | SFEBES2019

Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress

Cuozzo Federica , Nasteska Daniela , Thakker Alpesh , Westbrook Rebecca , Bakar Rula Bany , Cantley James , Tennant Daniel , Hodson David J

Aims: Prolyl-4 hydroxylase domain protein 3 (PHD3) is an alpha ketoglutarate-dependent dioxygenase involved in the oxygen-dependent regulation of cell phenotype. While PHD3 has been reported to suppress insulin sensitivity in the liver, little is known about effects of the enzyme in insulin-secreting β-cells.Methods: βPHD3−/− mice were generated by crossing the Ins1Cre driver line with animals bearing a floxed Egln3</...

ea0065oc2.5 | Neuroendocrinology, Pituitary and Neoplasia | SFEBES2019

Efnb2 controls pituitary gland development by regulating proliferation of the pituitary stem/progenitor cells and EMT within the pituitary stem cell niche

Gualtieri Angelica , Nicholson James , Tan Rachael , Jimenez Fernando , Dattani Mehul , Guasti Leonardo , Gaston-Massuet Carles

Efnb2 encodes for the ligand Ephrinb2 that binds to its cognate Eph receptor, with which plays an integral role in angiogenesis, stem cell regulation and tumorigenesis. Using a pituitary-specific Cre-driver (Hesx1Cre), we conditionally deleted Efnb2 from the early stem/progenitor cells (PSCs) of the developing pituitary gland. We found that Efnb2 is expressed in PSCs both during embryogenesis and adulthood, suggesting its...

ea0065p150 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Breast cancer in MEN1: coincidence or association?

Cheah Seong Keat , Bisambar Chad , Pitfield Deborah , Giger Olivier , Hoopen Rogier ten , Martin Jose Ezequiel , Clark Graeme , Park Soo-Mi , Parkinson Craig , Challis Bejamin , Casey Ruth

A 38 year old female was identified as carrying a heterozygous pathogenic MEN1 variant (c.13404delG) through predictive testing, following a diagnosis of familial hyperparathyroidism. Routine screening for hyperparathyroidism and pituitary disease was negative. However, a CT thorax-abdomen-pelvis revealed a 41 mm pancreatic tail mass. Biopsy via endoscopic ultrasound confirmed a well-differentiated (grade 1) pancreatic neuroendocrine tumour (pNET) with MIB1<1%. Bi...

ea0065p197 | Metabolism and Obesity | SFEBES2019

Immature β-cells are required for normal islet function and insulin release

Nasteska Daniela , Fine Nicholas H F , Ashford Fiona B , Smith Gabrielle , Bakhti Mostafa , Bastidas-Ponce Aimee , Rutter Guy A , Lickert Heiko , Zhou Qiao , Akerman Ildem , Hodson David J

Background: A normal islet includes both mature and immature β-cells, with the former possessing higher insulin content and the latter displaying better proliferative capacity. However, it remains unknown whether immature β-cells also contribute to the regulation of insulin release, especially by commanding the activity of their mature counterparts.Materials and methods: Pdx1, Mafa, and Ngn3 were overexpressed in &#94...

ea0067o2 | Oral Presentations | EYES2019

Occurrence of second primary malignancy in medullary thyroid cancer (MTC) patients

Simeakis George , Saltiki Katerina , Zapanti Evangelia , Kassis Evanthia , Alevizaki Maria

Objectives: Coexistence of two different malignancies is frequently reported. Sometimes occurs in the context of well-established syndromes like MEN2. Rearranged during transfection (RET), is an oncogenic driver activated in different kinds of neoplasias such as: MTC, Differentiated Thyroid Cancer (DTC), Non-Small Cell Lung Cancer (NSCLC). We have previously reported an increased prevalence of DTC in familial MTC patients carrying the RET (G533C) mutation. Ai...

ea0063gp5 | Adrenal and Neuroendocrine - Tumour | ECE2019

Pheochromocytoma’s of MENX rats belong to the pseudo-hypoxia cluster

Mohr Hermine , Gulde Sebastian , de Martino Daniela , Richter Susan , Pellegata Natalia

Pheochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors derived from chromaffin cells of the adrenal medulla and paraganglia of the autonomic nervous system, respectively. Despite a common origin, these tumors are quite heterogeneous in terms of driver mutations, copy number alterations and activated downstream-signaling pathways. Genome wide expression analysis has identified at least three main tumor clusters: a pseudo-hypoxic cluster, one with activation ...

ea0063p15 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Immunohistochemical characteristics of adrenal tumors in patients with primary aldosteronism

Romanova Natalia , Selivanova Lilya , Platonova Nadezhda , Troshina Ekaterina , Abrosimov Aleksandr

Introduction: CYP11B2 is a key enzyme of primary aldosteronism, and several factors are involved in the regulation of CYP11B2 expression and the overproduction of aldosterone. Somatic mutations in aldosterone-driver genes are strongly associated with CYP11B2 expression and have been only detected in the CYP11B2-positive tumor area, indicating that aldosterone producing adenoma (APA) intratumoral heterogeneity corresponds to non-uniform CYP11B2 expression in neoplastic cells. I...

ea0049s7.1 | Crosstalk between bone &amp; other organ(ism)s | ECE2017

Immune system

D'Amelio Patrizia

The immune system has been recognized as one of the most important regulators of bone turnover and its de-regulation is implicated in several bone diseases as post-menopausal osteoporosis and inflammatory bone loss. The study of the relationship between immune system and bone metabolism is generally indicated under the term ‘osteoimmunology’, the vast majority of these studies have been performed in animal models, however several data have been confirmed also in huma...

ea0049s30.3 | Moving away from old-fashioned steroidogenesis: what are the clinical implications? | ECE2017

Glucocorticoid production in primary aldosteronism – from mechanisms to clinical implications

Beuschlein Felix

Adrenal aldosterone excess is the most common cause of secondary hypertension and is associated with increased cardiovascular morbidity and mortality. However, adverse metabolic risk in primary aldosteronism extends beyond hypertension, with increased rates of insulin resistance, type 2 diabetes, and osteoporosis, which cannot be easily explained by aldosterone excess but would rather be associated with oversecretion of glucocorticoids. Over the last years, exome sequencing ha...